MoneyWorks4Me

Astal Laboratories - Quaterly Results

12 Aug 2025 Evaluate
The topline surged 92.66% to Rs. 253.27 millions for the June 2025 quarter as against Rs. 131.46 millions during the corresponding quarter last year.Net profit stood at Rs. 20.90  millions  compared to Rs. 16.89 millions in the corresponding previous quarter,high by 23.74%.OP of the company witnessed a marginal growth to 32.14 millions from 24.14 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 253.27 131.46 92.66 253.27 131.46 92.66 642.31 236.48 171.61
Other Income 0.56 0.34 64.71 0.56 0.34 64.71 1.25 0.13 861.54
PBIDT 32.14 24.14 33.14 32.14 24.14 33.14 129.02 11.28 1043.79
Interest 3.01 0.63 377.78 3.01 0.63 377.78 7.01 0.11 6272.73
PBDT 29.13 23.51 23.90 29.13 23.51 23.90 122.01 11.17 992.30
Depreciation 1.20 0.13 823.08 1.20 0.13 823.08 2.23 0.30 643.33
PBT 27.93 23.38 19.46 27.93 23.38 19.46 119.78 10.87 1001.93
TAX 7.03 6.49 8.32 7.03 6.49 8.32 30.52 3.02 910.60
Deferred Tax 2.47 0.26 850.00 2.47 0.26 850.00 1.11 0.08 1287.50
PAT 20.90 16.89 23.74 20.90 16.89 23.74 89.26 7.85 1037.07
Equity 98.46 98.46 0.00 98.46 98.46 0.00 98.46 98.46 0.00
PBIDTM(%) 12.69 18.36 -30.89 12.69 18.36 -30.89 20.09 4.77 321.11
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..